30 November 2023
30 November 2023
The agency has received reports of T-cell malignancies in patients who have previously received CAR-T cell immunotherapies.
Claire Skentelbery, the director general of EuropaBio, discusses potential challenges with the latest changes to the EU’s pharmaceutical legislation.
Prism Biolab is entitled to receive development and commercial milestone payments of up to $660m from Lilly.
KOLs have expressed their skepticism and uncertainty regarding the therapy to GlobalData.
Manufacturing of cell and gene therapies is a complex process that requires precise planning to ensure timely completion and a cost-contained procedure.
Candel has fired 50% of its workforce and directed its resources to advance the development of CAN-2409 and CAN-3110.
The company has commenced a first-in-human clinical trial of ABX1100 with initial findings expected in 2024.
A Phase Ib clinical trial of the therapeutic will commence in early 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.
Give your business an edge with our leading industry insights.
